INVESTIGATION OF THE SAFETY AND EFFICACY OF USING TARGETED RADIOTHERAPY TO ELIMINATE A HUMAN NEURAL STEM CELL NICHE THAT IS CO-OPTED BY GLIOBLASTOMA CELLS IN NEWLY-DIAGNOSED PATIENTS.

PI: Nader Sanai, M.D.
Director, Division of Neurosurgical Oncology
Director, Barrow Brain Tumor Research Center
Barrow Neurological Institute